Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Colivicchi

Showing results (1-10 of 486) with videos related to

Pageof 49
Sort By:
Annals of Internal Medicine|January 31, 2022
In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleedingFurio Colivicchi
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 6, 2014
[From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?]Furio Colivicchi
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[The evolution of hypercholesterolemia treatment]Furio Colivicchi
Cardiology|May 13, 2019
Traditional Cardiovascular Risk Factor and Psychosocial Distress in Younger Coronary Patients: Delineating a Comprehensive Approach for Secondary PreventionFurio Colivicchi
Cardiology|April 15, 2015
Statin reloading before noncardiac surgery: a simple, safe and effective approach for reducing the risk of perioperative myocardial infarctionFurio Colivicchi
Annals of Internal Medicine|July 3, 2023
In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcomeFurio Colivicchi
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Presentation]Furio Colivicchi
Cardiology|June 8, 2020
Overcoming Statin Intolerance in Clinical Practice: An Enduring EffortFurio Colivicchi, Giuseppe Imperoli
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 10, 2004
[Optimal coronary revascularization in type 2 diabetes mellitus]Furio Colivicchi, Carmine Riccio
Journal of the American College of Cardiology|August 1, 2020
Healthy Diet and Cardiovascular Prevention: Time to Go Further With a Precision Medicine Approach?Massimo Leggio, Furio Colivicchi
Pageof 49

Showing results (1-10 of 486) with videos related to

Sort By:
Pageof 49
Annals of Internal Medicine|January 31, 2022
In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleedingFurio Colivicchi
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 6, 2014
[From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?]Furio Colivicchi
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[The evolution of hypercholesterolemia treatment]Furio Colivicchi
Cardiology|May 13, 2019
Traditional Cardiovascular Risk Factor and Psychosocial Distress in Younger Coronary Patients: Delineating a Comprehensive Approach for Secondary PreventionFurio Colivicchi
Cardiology|April 15, 2015
Statin reloading before noncardiac surgery: a simple, safe and effective approach for reducing the risk of perioperative myocardial infarctionFurio Colivicchi
Annals of Internal Medicine|July 3, 2023
In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcomeFurio Colivicchi
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Presentation]Furio Colivicchi
Cardiology|June 8, 2020
Overcoming Statin Intolerance in Clinical Practice: An Enduring EffortFurio Colivicchi, Giuseppe Imperoli
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 10, 2004
[Optimal coronary revascularization in type 2 diabetes mellitus]Furio Colivicchi, Carmine Riccio
Journal of the American College of Cardiology|August 1, 2020
Healthy Diet and Cardiovascular Prevention: Time to Go Further With a Precision Medicine Approach?Massimo Leggio, Furio Colivicchi
Pageof 49